GI Interlab 2 Study: Measuring the Glycaemic Index (GI) of Foods

Sponsor
Glycaemic Index Testing, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00260858
Collaborator
Sydney University Glycaemic Index Research Services (Other), ILSI Europe (Other)
280
28
5
10
2

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the extent of and sources of variation in the glycaemic index values of foods measured by different laboratories around the world.

Condition or Disease Intervention/Treatment Phase
  • Drug: Test Meal: Reference food (glucose or white bread)
  • Drug: Test Meal: Pirate's Booty
  • Drug: Test Meal: Ceaprove wafer
  • Drug: Test Meal: Stretch Island Strawberry Fruit Leather
N/A

Detailed Description

The glycaemic index values of 3 different foods provided from a central location will be determined in each of 20-30 centers around the world. A standard protocol will be followed, but this protocol leaves room for variation in certain details, such as whether subjects are allowed to have coffee or tea with the test meals or only water, or the method of analyzing blood glucose. Methodologic details, subject demographic information (height, weight, age, and ethnicity), results of local calculations and raw data will be sent to a central location.

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Measuring the Glycaemic Index of Foods: Interlaboratory Study #2
Study Start Date :
Nov 1, 2005
Study Completion Date :
Apr 1, 2006

Outcome Measures

Primary Outcome Measures

  1. glycaemic index []

Secondary Outcome Measures

  1. within-individual variation of glycaemic responses []

  2. glycaemic responses assessed as incremental area under the curve []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy male or female subjects
Exclusion Criteria:
  • Diabetes

  • Pregnancy or lactation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Abernethy Research Gainsville Florida United States 32601
2 University of Buffalo Buffalo New York United States 14214-3000
3 Ohio State University Columbus Ohio United States 43210-1295
4 University of Sydney Sydney New South Wales Australia
5 International Diabetes Institute Melbourne Victoria Australia 3162
6 Glycemic Index Laboratories, Inc. Toronto Ontario Canada M5C 2X3
7 Institute of Nutrition and Food Safety, Chinese Centre for Disease Control and Prevention Beijing Beijing China 100050
8 The Royal Veterinary & Agricultural University Copenhagen Denmark
9 National Public Health Institute Helsinki Finland FIN-00300
10 Foodfiles Oy Kuopio Finland FI-70210
11 Biofortis Nantes France 44200
12 German Institute of Human Nutrition Potsdam-Rehbrucke Nuthetal Germany D-14558
13 University of Milan Milan Italy 20133
14 University of Parma Parma Italy 43100
15 University Sains Malaysia Kota Bharu Kelantan Malaysia
16 Nutriscience, BV Maastricht Netherlands 6200
17 University of Otago Dunedin Otago New Zealand
18 University of the Philippines Diliman Philippines
19 GI Foundation of South Africa Nelspruit Mpumalanga South Africa 1200
20 Potchefstroom University Potchefstroom Potchesfstroom South Africa 2520
21 Gotheburg University Gothenburg Gotheburg Sweden 413 90
22 Lund University Lund Sweden 222 41
23 University of the West Indies Champs Fleurs Trinidad Trinidad and Tobago
24 Reading Scientific Services, Ltd. Reading Berkshire United Kingdom
25 Oxford Brookes University Oxford Oxfordshire United Kingdom OX3 0BP
26 University of Surrey Guildford Surrey United Kingdom GU5 7XH
27 Leatherhead Food International Leatherhead Surrey United Kingdom KT22 7RY
28 Hammersmith Hospital London United Kingdom W12 0HS

Sponsors and Collaborators

  • Glycaemic Index Testing, Inc.
  • Sydney University Glycaemic Index Research Services
  • ILSI Europe

Investigators

  • Principal Investigator: Thomas MS Wolever, MD, PhD, University of Toronto
  • Principal Investigator: Janette C Brand-Miller, PhD, University of Sydney

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00260858
Other Study ID Numbers:
  • GIL5047
First Posted:
Dec 2, 2005
Last Update Posted:
Jun 9, 2006
Last Verified:
Jun 1, 2006

Study Results

No Results Posted as of Jun 9, 2006